Full text is available at the source.
Abstract
The Cas9-ACROBAT platform demonstrated near-complete suppression of off-target CRISPR activity while enabling effective genome editing.
- Multiple systems were developed to control the stability of the anti-CRISPR protein AcrIIA4 using small molecules.
- Ligand-dependent degradation or stabilization of AcrIIA4 was achieved by fusing it to various degrons.
- A theophylline-responsive riboswitch was engineered into the sgRNA scaffold to block Cas9-sgRNA assembly until ligand addition.
- The combination of riboswitch sgRNAs and degron-controlled AcrIIA4 resulted in effective regulation of CRISPR cutting, activation, and interference.
- This method allowed for the modulation of endogenous targets such as PLK1, CDKN1A, and CCND1.
Simplified